Skip to content
Artwork for Keeping Current CME

Keeping Current CME

Medscape

Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.

Play
  • 59 episodes
  • Avg 33 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • Friday · 14 min

    Don't Sleep on OSA: The Importance of Not Relying on Disease Severity in Making Treatment Decisions

    Apnea-hypopnea index (AHI) alone may not capture the full burden of obstructive sleep apnea (OSA). Explore how symptoms, quality of life, hypoxic burden, and individual risk inform treatment decisions. Credit available for this activity expires: 11/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/dont-sleep-osa-importance-not-relying-disease-severity-2026a10015sj?ecd=bdc_podcast_libsyn_mscpedu

  • Wednesday · 43 min

    Preparing for Novel Oral Endocrine Therapies in Early Breast Cancer

    Prepare your practice for the next generation of oral endocrine therapies. Credit available for this activity expires: 11/03/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle//viewarticle/preparing-novel-oral-endocrine-therapies-early-breast-cancer-2026a10015ev?ecd=bdc_podcast_libsyn_mscpedu

  • October 30 · 36 min

    Shared Voices: The Patient Journey in Obesity-Linked Liver Disease

    Explore patient journeys and multidisciplinary care management in obesity-linked liver disease. Credit available for this activity expires: 10/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/shared-voices-patient-journey-obesity-linked-liver-disease-2026a10013tx?ecd=bdc_podcast_libsyn_mscpedu

  • October 30 · 31 min

    Navigating the Data: Patient Eligibility for Novel Oral Therapies in EBC

    Did you know that EBC patients may stop treatment early, due to safety or tolerability, increasing risk of recurrence, hence the need for newer options? Credit available for this activity expires: 10/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-data-patient-eligibility-novel-oral-therapies-ebc-2026a10014e1?ecd=bdc_podcast_libsyn_mscpedu

  • October 29 · 38 min

    TED Paradigm Shift: Implications of New Treatments and Evolving Care Standards

    Could the latest targeted therapies reshape outcomes for your TED patients? Credit available for this activity expires: 10/29/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/ted-paradigm-shift-implications-new-treatments-and-evolving-2026a10012yt?ecd=bdc_podcast_libsyn_mscpedu

  • October 28 · 25 min

    Primary Care Bootcamp in Obstructive Sleep Apnea: Going Beyond the Obvious in Diagnosing OSA

    Do you know the spectrum of risk factors associated with obstructive sleep apnea (OSA)? Listen to our expert faculty to learn more. Credit available for this activity expires: 10/27/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/primary-care-bootcamp-obstructive-sleep-apnea-going-beyond-2026a1001127?ecd=bdc_podcast_libsyn_mscpedu

  • October 22 · 38 min

    From Pathway to Prescription in Alopecia Areata

    Experts discuss new clinical trial data and long-term safety of Janus kinase (JAK) inhibitors in alopecia areata (AA). Credit available for this activity expires: 10/21/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/pathway-prescription-alopecia-areata-2026a10012z7?ecd=bdc_podcast_libsyn_mscpedu

  • October 15 · 30 min

    The Next Frontier in SLE Management: Integrating Science With Targeted Treatment Strategies

    Experts discuss recent clinical guidelines and trial data on JAK inhibitors for systemic lupus erythematosus (SLE) treatment. Credit available for this activity expires: 10/15/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/next-frontier-sle-management-integrating-science-targeted-2026a10011xs?ecd=bdc_podcast_libsyn_mscpedu

  • October 13 · 30 min

    From Itch to Insight: The Prurigo Nodularis Countdown

    Experts discuss the latest efficacy and safety data on systemic treatments for prurigo nodularis. Credit available for this activity expires: 10/12/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/itch-insight-prurigo-nodularis-countdown-2026a10010t5?ecd=bdc_podcast_libsyn_mscpedu

  • October 9 · 33 min

    Beyond Injectables: Where Do Oral Treatments Fit in Obesity Management?

    Where do oral obesity medications fit alongside injectables, and how can you match the right option to the right patient? Credit available for this activity expires: 10/09/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-injectables-where-do-oral-treatments-fit-obesity-2026a10010xc?ecd=bdc_podcast_libsyn_mscpedu

  • October 1 · 38 min

    Non-Obstructive HCM Uncovered: Mechanisms, Burden, and the Road to Targeted Therapy

    Non-obstructive HCM, the milder disease? Think again. Uncover cellular drivers, diagnostic strategies, and landmark trial results that are reshaping care. Credit available for this activity expires: 9/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/non-obstructive-hcm-uncovered-mechanisms-burden-and-road-2026a10010dc?ecd=bdc_podcast_libsyn_mscpedu

  • September 30 · 37 min

    Advancing Clinical Management in Bipolar Depression: Therapeutic Options and Team-Based Care

    Are you familiar with the therapeutic options for managing bipolar depression? Listen to our expert faculty to learn more. Credit available for this activity expires: 9/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-clinical-management-bipolar-depression-therapeutic-2026a1000zzr?ecd=bdc_podcast_libsyn_mscpedu

  • September 29 · 29 min

    Erosive Esophagitis Beyond Protein Pump Inhibitors: Clinical Application of Potassium-Competitive Acid Blocker Therapy

    Experts discuss data on potassium-competitive acid blocker (PCAB) therapy and treatment considerations for patients with erosive esophagitis (EE). Credit available for this activity expires: 9/29/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/erosive-esophagitis-beyond-protein-pump-inhibitors-clinical-2026a1000zkx?ecd=bdc_podcast_libsyn_mscpedu

Showing 1–20 of 59 episodes